Life Bio is a clinical-stage biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. The company's proprietary Partial Epigenetic Reprogramming (PER) platform utilizes three transcription factors-OCT4, SOX2, and KLF4 (OSK)-to restore older and damaged cells to a younger and healthier state. This innovative approach targets a root cause of aging at the epigenetic level, thereby offering the potential to address a wide range of serious age-related diseases.

Key Contact